Attached files
| file | filename |
|---|---|
| 10-K - 10-K - AMYLIN PHARMACEUTICALS INC | a2196628z10-k.htm |
| EX-18 - EXHIBIT 18 - AMYLIN PHARMACEUTICALS INC | a2196628zex-18.htm |
| EX-31.1 - EXHIBIT 31.1 - AMYLIN PHARMACEUTICALS INC | a2196628zex-31_1.htm |
| EX-21.1 - EXHIBIT 21.1 - AMYLIN PHARMACEUTICALS INC | a2196628zex-21_1.htm |
| EX-31.2 - EXHIBIT 31.2 - AMYLIN PHARMACEUTICALS INC | a2196628zex-31_2.htm |
| EX-32.1 - EXHIBIT 32.1 - AMYLIN PHARMACEUTICALS INC | a2196628zex-32_1.htm |
| EX-10.26 - EXHIBIT 10.26 - AMYLIN PHARMACEUTICALS INC | a2196628zex-10_26.htm |
| EX-10.53 - EXHIBIT 10.53 - AMYLIN PHARMACEUTICALS INC | a2196628zex-10_53.htm |
| EX-10.54 - EXHIBIT 10.54 - AMYLIN PHARMACEUTICALS INC | a2196628zex-10_54.htm |
| EX-10.52 - EXHIBIT 10.52 - AMYLIN PHARMACEUTICALS INC | a2196628zex-10_52.htm |
| EX-10.10 - EXHIBIT 10.10 - AMYLIN PHARMACEUTICALS INC | a2196628zex-10_10.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statements on Form S-8 (No.’s 33-45092, 33-47604, 33-85512, 333-2894, 333-2896, 333-51577, 333-82965, 333-39124, 333-61660, 333-108050, 333-115187, 333-121496, 333-126513, 333-134528, 333-145202, 333-151503 and 333-160120) and Form S-3 (No.’s 33-83602, 333-2898, 333-14143, 333-15295, 333-58831, 333-59639, 333-87033, 333-33340, 333-61144, 333-75066, 333-101278, 333-108008, 333-111086, 333-115509, 333-127949, 333-127950, 333-132730, 333-136860, and 333-145200), of our reports dated February 26, 2010, with respect to the consolidated financial statements and schedule of Amylin Pharmaceuticals, Inc., and the effectiveness of internal control over financial reporting of Amylin Pharmaceuticals, Inc. included in this Annual Report (Form 10-K) for the year ended December 31, 2009.
|
|
/s/ Ernst & Young LLP |
|
|
|
|
San Diego, California |
|
|
February 26, 2010 |
|